Clinical trials
Phase 3 Recurrence trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Active, not recruiting | 6 |
| Recruiting | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| Biogen | 5 |
| Celgene | 2 |
| Pfizer | 2 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| Centocor, Inc. | 1 |
| GlaxoSmithKline | 1 |
| Indian Council of Medical Research | 1 |
| Janssen Research & Development, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 22 |
| Multiple Sclerosis | 7 |
| Multiple Myeloma | 6 |
| Multiple Sclerosis, Relapsing-Remitting | 3 |
| Breast Neoplasms | 2 |
| Neoplasms | 2 |
| Unilateral Breast Neoplasms | 2 |
| Biliary Tract Neoplasms | 1 |
| Gallbladder Neoplasms | 1 |
| Leukemia, B-Cell | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.